Heini Honkanen appointed as Medaffcon’s Market Access Lead
Heini Honkanen has been appointed as Medaffcon’s Market Access Lead. The new Market Access Team was created when the previous Price and Reimbursement and HE & Access Teams were merged.
Modelling is an essential part of health economic analyses. It is a central tool for authorities, experts and payers to support decision-making regarding healthcare resource utilization.
Modelling is an essential part of health economic analyses. It is a central tool for authorities, experts and payers to support decision-making regarding healthcare resource utilization. With the help of modelling, fragmented research data, observations, and experiences, as well as justified assumptions, are compiled into a synthesis that aims to anticipate and predict the impact of healthcare interventions on individuals, patient groups, healthcare and society.
Modelling not only answers the decision maker’s question about the most likely outcome, but also the probability of extreme scenarios, as well as the credible range of results. In its most general form, modelling relates to the cost-effectiveness of an intervention. This means that the costs are examined together with the health benefits of the intervention. Another common target of modelling is the budget impact of an intervention. In this case, the focus is on the intervention’s impact on the use of resources. These can be even directly related to the intervention, or indirectly to the entire treatment path of a patient.
Medaffcon has the ability to complete modelling projects from the localization of the customer’s ready global core models to the comprehensive construction of models from the beginning. We have been doing modelling for over 10 years, providing our customers with an effective tool to support decision making.
Read more about our interactive value tools that combine health economic modelling, real world evidence and data science into one easy to use product.
Heini Honkanen has been appointed as Medaffcon’s Market Access Lead. The new Market Access Team was created when the previous Price and Reimbursement and HE & Access Teams were merged.
Medaffconin Tanja Nieminen ja Heini Honkanen osallistuivat terveystaloustieteen tutkimukseen ja terveydenhuollon menetelmien arviointiin keskittyvään ISPOR-kongressiin marraskuussa.
In health economic studies, real world evidence (RWE) can produce additional knowledge, especially on the…
Health Economist
Market Access Lead
M.Sc. (Health Economics)
+358 44 326 4477
heini.honkanen@medaffcon.fi
Heini joined Medaffcon’s Market Access team in the spring of 2018. Heini holds master’s degree in health and social sciences, majoring in Health Economics. Prior to moving into the field of pharmacoeconomics, Heini has worked as an entrepreneur in the health and sport industry. At Medaffcon, Heini works as Market Access Lead with various market access processes and health technology assessments.
Heini has a wide range of expertise in the price and reimbursement processes and health technology assessments in multiple therapy areas. Heini is interested in the possibilities to turn data into understandable information to support healthcare decision-making and thus increase the patient’s well-being. Together with her team and clients she strives to facilitate the provision of bespoke solutions for customers’ pricing and market access needs.